Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

April 30, 2006

Study Completion Date

May 31, 2007

Conditions
Major Depressive Disorder
Interventions
DRUG

Quetiapine fumarate

DRUG

Duloxetine

Trial Locations (34)

Unknown

Research Site, Birmingham

Research Site, Scottsdale

Research Site, Beverly Hills

Research Site, San Diego

Research Site, Sherman Oaks

Research Site, Wildomar

Research Site, Boca Raton

Research Site, Bradenton

Research Site, Jacksonville

Research Site, Orlando

Research Site, Tampa

Research Site, West Palm Beach

Research Site, Edwardsville

Research Site, Lake Charles

Research Site, Baltimore

Research Site, Haverhill

Research Site, Okemos

Research Site, Saint Paul

Research Site, St Louis

Research Site, Princeton

Research Site, Albuquerque

Research Site, New York

Research Site, Dayton

Research Site, Mayfield Village

Research Site, Oklahoma City

Research Site, Salem

Research Site, Philadelphia

Research Site, Columbia

Research Site, Memphis

Research Site, Houston

Research Site, Salt Lake City

Research Site, Richmond

Research Site, Kirkland

Research Site, Morgantown

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY